Osteoporosis drug Bazedoxifene shows Promise in Cancer of Breast Resistant to Tamoxifen

It remains to be seen, if bazedoxifene can come out as a winner, to be recommended for treatment of breast cancer too; in which case, it will be a drug addressing two issues at one time i.e. breast cancer treatment and prevention of osteoporosis in those patients.
Read more; Approved for Osteoporosis, Bazedoxifene (BZA) shows Promise, Even in Cancer of Breast Resistant to Tamoxifen ~ From A Clinician’s Bioscope.